In Vitro Activities of Antifungal Agents against Clinical Isolates of Dermatophytes from Animals

被引：31

作者：

Itoi, Sayuri ^{[1
]}

Kano, Rui ^{[1
]}

Hasegawa, Atsuhiko ^{[2
]}

Kamata, Hiroshi ^{[1
]}

机构：

[1] Nihon Univ, Sch Vet Med, Dept Pathobiol, Fujisawa, Kanagawa 2520880, Japan

[2] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo 1920395, Japan

来源：

JOURNAL OF VETERINARY MEDICAL SCIENCE | 2012年 / 74卷 / 08期

关键词：

azole; dermatophyte; drug susceptibility; terbinafine; SUSCEPTIBILITY; STRAINS;

D O I：

10.1292/jvms.12-0057

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Although the susceptibility of dermatophytes to anti fungal drugs is well documented in humans, the effectiveness in animals has not been previously investigated. The in vitro susceptibility of 54 clinical isolates from animal dermatophytoses to ketoconazole (KTZ), itaconazole (ITZ) and terbinafine (TFN) was measured using microdilution assay (CLSI M38-A2 test) and by the E-test (KTZ and ITZ). All 3 drugs showed anti fungal activity, while KTZ displayed the broadest minimum inhibition concentration (MIC) rang (0.125-16 mu g/ml) against M. canis and M. gypseuni. The MIC of KTZ and TFN was almost the same for human and animal isolates of T mentagrophytes and T. rubrum. The MIC of TFN was almost the same for dermatophytes isolated from humans and animals.

引用

页码：1067 / 1069

页数：3

共 50 条

[31] In Vitro Activities of Antifungal Agents Against Rhodotorula Species
Pelaez, T.
Gama, B.
Munoz, P.
Ruiz-Serrano, M. J.
Guinea, J.
Flores, R.
Pedromingo, M.
Bouza, E.
MYCOSES, 2009, 52 : 36 - 36
[32] Antifungal activities of essential oils of Syzygium aromaticum, Piper betle, and Ocimum sanctum against clinical isolates of canine dermatophytes
Aiemsaard, Jareerat
Punareewattana, Korawuth
SCIENCEASIA, 2017, 43 (04): : 223 - 228
[33] In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates
Wexler, HM
Engel, AE
Glass, D
Li, CD
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4413 - 4417
[34] In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis
Carrillo-Muñoz, AJ
Guglietta, A
Palacín, C
Casals, J
del Valle, O
Guardià, C
Rodríguez, V
Quindós, G
CHEMOTHERAPY, 2004, 50 (06) : 308 - 313
[35] Evaluation of in vitro susceptibility of dermatophytes to coral antifungal agents
Hazen, KC
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (05) : S125 - S128
[36] In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents
Barchiesi, Francesco
Silvestri, Carmela
Arzeni, Daniela
Ganzetti, Giulia
Castelletti, Sefora
Simonetti, Oriana
Cirioni, Oscar
Kamysz, Wojciech
Kamysz, Elzbieta
Spreghini, Elisabetta
Abruzzetti, Alessandra
Riva, Alessandra
Offidani, Anna M.
Giacometti, Andrea
Scalise, Giorgio
MEDICAL MYCOLOGY, 2009, 47 (03) : 321 - 326
[37] New Antifungal Agents and New Formulations Against Dermatophytes
Gupta, Aditya K.
Foley, Kelly A.
Versteeg, Sarah G.
MYCOPATHOLOGIA, 2017, 182 (1-2) : 127 - 141
[38] In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
Abastabar, Mahdi
Jedi, Ali
Guillot, Jacques
Ilkit, Macit
Eidi, Samaneh
Hedayati, Mohammad Taghi
Shokohi, Tahereh
Ghazvini, Roshanak Daie
Rezaei-Matehkolaei, Ali
Katiraee, Farzad
Javidnia, Javad
Ahmadi, Bahram
Badali, Hamid
MYCOSES, 2019, 62 (11) : 1069 - 1078
[39] In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp.
Najafzadeh, Mohammad J.
Badali, Hamid
Illnait-Zaragozi, Maria Teresa
De Hoog, G. Sybren
Meis, Jacques F.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (04) : 1636 - 1638
[40] In Vitro Activities of Eight Antifungal Drugs against 104 Environmental and Clinical Isolates of Aureobasidium pullulans
Najafzadeh, M. Javad
Sutton, Deanna A.
Keisari, M. Saradeghi
Zarrinfar, H.
de Hoog, G. Sybren
Chowdhary, Anuradha
Meis, Jacques F.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5629 - 5631

← 1 2 3 4 5 →